Launch Intelligence Calculator

Patient Intelligence Gap Calculator

How much patient evidence does your launch actually need?

Answer 3 questions and receive:

Recommended patient sample size
Markets to prioritize
Expected conversation volume
Key launch risks patients are already discussing
Benchmark against similar disease launches

Calculate my Patient Intelligence Gap

Life science teams already reducing launch risk with patient intelligence

01Diseases

02Markets

03Focus

04Details

01 — Disease areas

Which diseases are you targeting?

We structure patient conversations across 20+ diseases. The more specific you are, the sharper your scope.

02 — Target markets

Which countries are you targeting?

Every market is different. Your scope reflects your specific markets, not industry averages.

Select countries▼

03 — Your focus

Select your launch objectives

Select all that apply.

Choose your focus areas▼

Mapping patient journeys…

Here’s what you need for a successful launch in your disease area

Schedule my patient intelligence review

Estimated patient conversations

—

Minimum patient voice needed across your selected disease-market scope.

Min. interview hours

—

Total patient voice hours across all disease-market combinations.

Structured patient data points

—

Journey, treatment, sentiment and unmet need signals captured across the cohort.

Benchmark patient signal coverage

——

Estimated visibility into patient signals for a typical launch team before dedicated patient intelligence collection.

Expected insights from this scope

8 common launch messaging risks

4 adherence barriers

5 unmet needs not captured in trials

Market-level differences across selected countries

Structured across

Treatment journey

Diagnosis barriers

Therapy switching

Patient sentiment

Country-specific patient needs

Ready to close your patient intelligence gap?

With 60,000 patients across 22 conditions in 14 markets, mama health can help turn your estimated cohort, conversations, data points and coverage score into launch-ready evidence.

Schedule my patient intelligence review

Your launch team is making decisions about patients they have never heard from.

Every function has a different view of the patient. mama health gives all teams one shared source of real patient intelligence — so launch decisions stop being built on assumptions.

Optimize launches on real patient behavior.

Understand why patients switch, delay, or drop off. Primary patient conversations surface the behavioral reasons behind every market signal — so your team can act, not just react.

Evidence the experience trial data doesn't capture.

RWE tells you what was prescribed. It doesn't tell you why patients stopped. mama health structures both — ready for evidence dossiers and advisory boards.

Test messaging on the people it's for.

Brand teams test concepts on synthetic audiences — and find out months later patients heard something different. Close the loop in days with real cohort benchmarks.